Using best practices to manage psychiatric medications under medicaid

Psychiatric Services

Volumn 55, Issue 11, 2004, Pages 1227-1229

  Parks, Joseph ^a,b   Surles, Richard ^c  

^a Missouri Department of Mental Health   (United States)

^b University of Missouri   (United States)

^c Comprehensive Neuro Science ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; EXPERIENCE; HEALTH CARE POLICY; MANAGED CARE; MEDICAID; MEDICAL PRACTICE; MENTAL HEALTH; PRESCRIPTION; PSYCHIATRIC TREATMENT; QUALITY CONTROL; RESOURCE ALLOCATION; SHORT SURVEY;

ADVISORY COMMITTEES; BENCHMARKING; BRITISH COLUMBIA; COST SAVINGS; CROSS-CULTURAL COMPARISON; DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; FORMULARIES; HUMANS; MEDICAID; MISSOURI; PSYCHOTROPIC DRUGS; RESOURCE ALLOCATION;

EID: 7444264536     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.55.11.1227     Document Type: Short Survey

References (3)

1. Gencarelli DM: Medicaid prescription drug coverage: state efforts to control costs. National Health Policy Forum Issue Brief 790:1-17, 2003
2. Tamblyn R, Laprise R, Hanley JA, et al: Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 285:421-429, 2001.
3. Soumerai SB: Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Affairs 23(1):135-146, 2004